Quick Answer
Orchestra BioMed Holdings, Inc. reported Net Income of -$52.70 million for fiscal year 2025.
Orchestra BioMed Holdings, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$52.70M | +13.6% |
| 2024 | -$61.02M | -24.2% |
| 2023 | -$49.12M | -46.2% |
| 2022 | -$33.61M | -8773.3% |
| 2021 | -$378.8K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$20.83M | -35.0% | -7.6% |
| June 30, 2025 | -$19.36M | -21.2% | -3.2% |
| March 31, 2025 | -$18.75M | -39.3% | -21.6% |
| September 30, 2024 | -$15.43M | -15.8% | +3.5% |
| June 30, 2024 | -$15.98M | -32.7% | -18.7% |
| March 31, 2024 | -$13.46M | -23.1% | -1.1% |
| September 30, 2023 | -$13.32M | -29.5% | -10.5% |
| June 30, 2023 | -$12.05M | -53.5% | -10.1% |
- Orchestra BioMed Holdings, Inc. showed an increase of +13.6% in Net Income compared to the prior fiscal year.
- Over the 2021–2025 period, Orchestra BioMed Holdings, Inc.’s net income has declined by 13814.3% (from -$378.8 thousand to -$52.70 million).
- The most recent figure is from Orchestra BioMed Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: